Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Symphony Alpha Ventures is a venture capital firm established to concentrate on early-stage healthcare IT companies. Founded in the United States, the firm partners with promising healthcare technology startups that demonstrate strong entrepreneurial teams and the potential for recurring SaaS revenues. The firm utilizes its parent company, Symphony Corporation, to facilitate the development and commercialization of healthcare solutions.
Currently, Symphony Alpha Ventures operates with a focus on early-stage investments, specifically in the healthcare technology sector. The firm has successfully facilitated multiple exits and has developed a reputation for its strategic approach to investing in companies that leverage innovative technologies. Their investment strategy is designed to support startups in refining their business models and accelerating their market penetration.
Symphony Alpha Ventures invests primarily in early-stage healthcare technology companies, particularly those that utilize innovative technologies to enhance workflow and improve healthcare delivery. The firm targets companies that have achieved a minimum viable product (MVP) and emphasizes SaaS models that leverage cloud-based technologies. Their investment strategy encompasses capital investment, product development support, and strategic partnerships.
Investment stages include pre-seed, seed, and seed-plus, allowing the firm to engage with startups at various points in their development. Symphony Alpha Ventures seeks to partner with companies that demonstrate strong potential for growth and recurring revenue, particularly in the healthcare sector. Their approach is designed to refine business models and accelerate market penetration, ensuring that portfolio companies are well-positioned for success.
Symphony Alpha Ventures has a notable portfolio with several successful exits, including:
Additionally, Symphony Alpha Ventures developed the SymphonyCare technology platform, which was acquired by Influence Health to enhance patient engagement offerings. They also contributed to products for Liazon Corporation, which was acquired for $215 million in November 2013, and Symphony Data Corporation, acquired by Zavata in 2005.
Ravi Kalla - Managing Director. Ravi has extensive experience in venture capital and healthcare technology, having led multiple successful investments in the sector.
Tom Carmona - Managing Director. Tom brings a wealth of knowledge in early-stage investments and has a strong background in supporting healthcare startups.
Submit your pitch through their website's contact form for consideration.
In August 2022, Symphony Alpha Ventures announced the acquisition of Starchup by Cents, marking a significant exit for the firm. In June 2022, ReviewTrackers was acquired by InMoment, and Hitch Works was acquired by ServiceNow, both notable exits that highlight the firm's successful investment strategy.
Additionally, Symphony Alpha Ventures developed the SymphonyCare technology platform, which was acquired to enhance patient engagement offerings, further demonstrating the firm's active role in the healthcare technology sector.
What are the investment criteria for Symphony Alpha Ventures?
Symphony Alpha Ventures focuses on early-stage healthcare technology companies, particularly those with a minimum viable product (MVP) and a SaaS model. They look for startups that leverage innovative technologies to enhance workflow and improve healthcare delivery.
How can startups apply or pitch to Symphony Alpha Ventures?
Startups interested in pitching to Symphony Alpha Ventures should prepare a detailed presentation that outlines their business model, market potential, and technology. Direct outreach via their website is recommended for initial contact.
What makes Symphony Alpha Ventures different from other VC firms?
The firm leverages its parent company, Symphony Corporation, to provide additional resources and support for portfolio companies, including product development and strategic partnerships.
What is the geographic scope of Symphony Alpha Ventures?
Symphony Alpha Ventures primarily invests in companies based in the United States, focusing on the healthcare technology sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Symphony Alpha Ventures invests in early-stage rounds, including pre-seed, seed, and seed-plus stages, which typically involve smaller investments compared to later-stage funding.
What type of post-investment involvement does Symphony Alpha Ventures have?
The firm actively supports its portfolio companies through product development assistance, strategic partnerships, and guidance on refining business models to accelerate growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.